Vanda Pharmaceuticals (VNDA) Prepaid Assets (2010 - 2026)
Vanda Pharmaceuticals recorded quarterly Prepaid Assets of $32.3 million in Q1 2026, up 19.63% quarter-over-quarter from $27.0 million in Q4 2025, and up 57.65% year-over-year from $20.5 million in Q1 2025.
Vanda Pharmaceuticals' Prepaid Assets history runs 17 years deep, the most recent figure standing at $32.3 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 57.65% year-over-year to $32.3 million; the TTM figure through Mar 2026 stood at $32.3 million (up 57.65% YoY), while the FY2025 annual figure was $27.0 million, up 75.0% from the prior year.
- Prepaid Assets came in at $32.3 million for Q1 2026 at Vanda Pharmaceuticals, up from $27.0 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $32.3 million in Q1 2026 to a low of $6.6 million in Q1 2023.
- A 5-year average of $17.5 million and a median of $17.7 million in 2022 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets plunged 73.95% in 2023 and soared 189.82% in 2025, its largest moves.
- Vanda Pharmaceuticals' Prepaid Assets stood at $17.7 million in 2022, then sank by 48.27% to $9.2 million in 2023, then surged by 68.16% to $15.4 million in 2024, then soared by 75.0% to $27.0 million in 2025, then grew by 19.63% to $32.3 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $32.3 million, $27.0 million, and $21.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.28 Mn |
| Dec 31, 2025 | 26.99 Mn |
| Sep 30, 2025 | 21.16 Mn |
| Jun 30, 2025 | 22.21 Mn |
| Mar 31, 2025 | 20.48 Mn |
| Dec 31, 2024 | 15.42 Mn |
| Sep 30, 2024 | 11.76 Mn |
| Jun 30, 2024 | 8.17 Mn |
| Mar 31, 2024 | 7.07 Mn |
| Dec 31, 2023 | 9.17 Mn |
| Sep 30, 2023 | 16.44 Mn |
| Jun 30, 2023 | 9.45 Mn |
| Mar 31, 2023 | 6.59 Mn |
| Dec 31, 2022 | 17.73 Mn |
| Sep 30, 2022 | 21.37 Mn |
| Jun 30, 2022 | 25.74 Mn |
| Mar 31, 2022 | 25.31 Mn |
| Dec 31, 2021 | 12.00 Mn |
| Sep 30, 2021 | 13.44 Mn |
| Jun 30, 2021 | 12.01 Mn |
| Mar 31, 2021 | 10.23 Mn |
| Dec 31, 2020 | 10.09 Mn |
| Sep 30, 2020 | 11.63 Mn |
| Jun 30, 2020 | 15.04 Mn |
| Mar 31, 2020 | 17.83 Mn |
| Dec 31, 2019 | 14.50 Mn |
| Sep 30, 2019 | 14.38 Mn |
| Jun 30, 2019 | 10.69 Mn |
| Mar 31, 2019 | 11.20 Mn |
| Dec 31, 2018 | 12.00 Mn |
| Sep 30, 2018 | 12.08 Mn |
| Jun 30, 2018 | 11.84 Mn |
| Mar 31, 2018 | 9.28 Mn |
| Dec 31, 2017 | 8.00 Mn |
| Sep 30, 2017 | 2.75 Mn |
| Jun 30, 2017 | 15.73 Mn |
| Mar 31, 2017 | 1.27 Mn |
| Dec 31, 2016 | 1.58 Mn |
| Sep 30, 2016 | 11.04 Mn |
| Jun 30, 2016 | 9.43 Mn |
| Mar 31, 2016 | 6.50 Mn |
| Dec 31, 2015 | 979,000.00 |
| Sep 30, 2015 | 8.69 Mn |
| Jun 30, 2015 | 5.36 Mn |
| Mar 31, 2015 | 1.78 Mn |
| Dec 31, 2014 | 270,000.00 |
| Sep 30, 2014 | 2.51 Mn |
| Jun 30, 2014 | 234,000.00 |
| Mar 31, 2014 | 33,000.00 |
| Dec 31, 2013 | 167,000.00 |
| Sep 30, 2013 | 2.41 Mn |
| Jun 30, 2013 | 2.65 Mn |
| Mar 31, 2013 | 51,000.00 |
| Dec 31, 2012 | 3.54 Mn |
| Sep 30, 2012 | 3.32 Mn |
| Jun 30, 2012 | 3.42 Mn |
| Mar 31, 2012 | 2.56 Mn |
| Dec 31, 2011 | 3.00 Mn |
| Sep 30, 2011 | 1.87 Mn |
| Jun 30, 2011 | 2.19 Mn |
| Dec 31, 2010 | 1.84 Mn |